Skip to content

In the BioHarmony Drug Report Database


Tavist (clemastine) is a small molecule pharmaceutical. Clemastine was first approved as Tavist on 1982-01-01. It is used to treat allergic rhinitis perennial, angioedema, and urticaria in the USA. The pharmaceutical is active against histamine H1 receptor. In addition, it is known to target P2X purinoceptor 7.
Trade Name Tavist
Common Name Clemastine
Indication allergic rhinitis perennial, angioedema, urticaria
Drug Class Antihistaminics (histamine-H1 receptor antagonists)
Get full access now